Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,832 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Radiomics of Periprostatic Fat and Tumor Lesion Based on MRI Predicts the Pathological Upgrading of Prostate Cancer from Biopsy to Radical Prostatectomy.
Liu WQ, Wei Y, Ke ZB, Lin B, Wu XH, Huang XY, Chen ZJ, Chen JY, Chen SH, Xue YT, Lin F, Chen DN, Zheng QS, Xue XY, Xu N. Liu WQ, et al. Among authors: chen zj, chen jy, chen sh, chen dn. Acad Radiol. 2024 Dec 26:S1076-6332(24)00890-0. doi: 10.1016/j.acra.2024.11.043. Online ahead of print. Acad Radiol. 2024. PMID: 39730248
Preoperative abdominal fat distribution and systemic immune inflammation were associated with response to intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle invasive bladder cancer.
Ke ZB, Chen H, Chen JY, Cai H, Lin YZ, Sun XL, Huang JB, Zheng QS, Wei Y, Xue XY, Xu N. Ke ZB, et al. Among authors: chen jy, chen h. Clin Nutr. 2021 Dec;40(12):5792-5801. doi: 10.1016/j.clnu.2021.10.019. Epub 2021 Nov 1. Clin Nutr. 2021. PMID: 34775222
Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage.
Ke ZB, Chen JY, You Q, Sun JB, Xue YT, Ye XJ, Chen SH, Xue XY, Sun XL, Chen DN, Wei Y, Zheng QS, Chen SM, Xu N. Ke ZB, et al. Among authors: chen jy, chen sh, chen dn, chen sm. J Cancer Res Clin Oncol. 2023 Jul;149(8):5071-5084. doi: 10.1007/s00432-022-04438-8. Epub 2022 Nov 4. J Cancer Res Clin Oncol. 2023. PMID: 36333565
Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study.
Ke ZB, Chen SM, Chen JY, Chen SH, You Q, Sun JB, Xue YT, Sun XL, Wu XH, Zheng QS, Wei Y, Xue XY, Xu N. Ke ZB, et al. Among authors: chen jy, chen sh, chen sm. Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1240-1251. doi: 10.1007/s00259-022-06047-6. Epub 2022 Nov 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 36416906
4,832 results